Search research articles
Contact Us
Filters
Showing results (611-620 of 1,095) with videos related to
Page
of 110
Sort By:
Archives of Neurology
|
May 11, 2011
Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy
Saul A Mullen, Carla Marini, Arvid Suls, et al.
Transplantation
|
December 2, 2016
Successful Continuation of HCV Treatment After Liver Transplantation
Carlos Fernández Carrillo, Gonzalo Crespo, Juan de la Revilla, et al.
JHEP Reports : Innovation in Hepatology
|
February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
Christiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
Current Urology
|
August 11, 2020
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma
Alessio Cortellini, Sebastiano Buti, Melissa Bersanelli, et al.
Cancer Treatment and Research Communications
|
May 10, 2025
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab
Giulia Claire Giudice, Sara Elena Rebuzzi, Giulia Mazzaschi, et al.
Cancer Immunology, Immunotherapy : CII
|
September 26, 2009
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer
Rodolfo Passalacqua, Carlo Buzio, Sebastiano Buti, et al.
BMC Medicine
|
May 4, 2017
Late presentation of chronic viral hepatitis for medical care: a consensus definition
Stefan Mauss, Stanislas Pol, Maria Buti, et al.
Digestive Diseases and Sciences
|
September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B
Naoky C Tsai, Patrick Marcellin, Maria Buti, et al.
Frontiers in Medicine
|
August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
Laia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
JHEP Reports : Innovation in Hepatology
|
September 25, 2023
HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
Luisa Roade, Mar Riveiro-Barciela, Maria Pfefferkorn, et al.
Page
of 110
Search research articles
Search
Showing results (611-620 of 1,095) with videos related to
Sort By:
Page
of 110
Archives of Neurology
|
May 11, 2011
Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy
Saul A Mullen, Carla Marini, Arvid Suls, et al.
Transplantation
|
December 2, 2016
Successful Continuation of HCV Treatment After Liver Transplantation
Carlos Fernández Carrillo, Gonzalo Crespo, Juan de la Revilla, et al.
JHEP Reports : Innovation in Hepatology
|
February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
Christiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
Current Urology
|
August 11, 2020
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma
Alessio Cortellini, Sebastiano Buti, Melissa Bersanelli, et al.
Cancer Treatment and Research Communications
|
May 10, 2025
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab
Giulia Claire Giudice, Sara Elena Rebuzzi, Giulia Mazzaschi, et al.
Cancer Immunology, Immunotherapy : CII
|
September 26, 2009
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer
Rodolfo Passalacqua, Carlo Buzio, Sebastiano Buti, et al.
BMC Medicine
|
May 4, 2017
Late presentation of chronic viral hepatitis for medical care: a consensus definition
Stefan Mauss, Stanislas Pol, Maria Buti, et al.
Digestive Diseases and Sciences
|
September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B
Naoky C Tsai, Patrick Marcellin, Maria Buti, et al.
Frontiers in Medicine
|
August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
Laia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
JHEP Reports : Innovation in Hepatology
|
September 25, 2023
HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
Luisa Roade, Mar Riveiro-Barciela, Maria Pfefferkorn, et al.
Page
of 110